Cover Image
市場調查報告書

體外診斷:全球市場概要

In Vitro Diagnostics - A Global Market Overview

出版商 Industry Experts 商品編碼 240527
出版日期 內容資訊 英文 498 Pages
訂單完成後即時交付
價格
Back to Top
體外診斷:全球市場概要 In Vitro Diagnostics - A Global Market Overview
出版日期: 2017年08月01日 內容資訊: 英文 498 Pages
簡介

全球體外診斷 (IVD) 市場規模,2014年達558億美元,預計2017年擴大到626億美元,並且至2022年達830億3,000萬美元。分子診斷,預計是成長最快速的IVD技術市場區隔,2017-2022年以約8%的年複合成長率,市場規模至2022年預計達到105億美元。

本報告提供全球體外診斷 (IVD) 市場相關資料,北美,歐洲,亞太地區,南美等各地區分析,以及各國分析,主要企業趨勢分析,主要打入市場企業簡介。

A部分:全球市場的預測

第1章 簡介

  • 產品概要

第2章 IVD法規 & 標準

  • 國際醫療設備法規當局論壇 (IMDRF) 及醫療設備法規國際調整化會議 (GHTF)
  • 美國
  • 歐洲
  • 中國
  • 日本

第3章 主要市場趨勢

  • 人口高齡化及疾病負擔IVD需求擴大貢獻
  • 臨床診斷預知、預測演進
  • 次世代定序改革臨床應用
  • 透過可攜式診斷系統,PCR的速度加速
  • 迅速DNA實驗提供PCR替換的空間

第4章 主要全球企業

  • Abbott Laboratories, Inc. (美國)
  • Becton, Dickinson and Company (美國)
  • Biomerieux SA (法國)
  • Bio-Rad Laboratories, Inc. (美國)
  • Danaher Corporation (美國)
  • ELITech Group (法國)
  • ERBA Diagnostics Mannheim GmbH (德國)
  • Hologic Inc. (美國)
  • Ortho Clinical Diagnostics (美國)
  • Roche Diagnostics Corporation (美國)
  • Siemens Healthineers, Inc. (美國)
  • Sysmex Corporation (日本)
  • Wefen Group (西班牙)

第5章 主要企業 & 產品趨勢

第6章 全球市場概要

  • 全球體外診斷市場概要:各產品類型
  • 全球體外診斷市場概要:各技術領域

B部分:地區市場預測

地區市場概要

第1章 北美

  • 北美的體外診斷市場概要:各地區
  • 北美的體外診斷市場概要:各產品類型
  • 北美的體外診斷市場概要:各技術領域
  • 主要企業
  • 北美的體外診斷市場:各國分析

第2章 歐洲

  • 歐洲的體外診斷市場概要:各地區
  • 歐洲的體外診斷市場概要:各產品類型
  • 歐洲的體外診斷市場概要:各技術領域
  • 主要企業
  • 歐洲的體外診斷市場概要:各二級地區

第3章 亞太地區

  • 亞太地區的體外診斷市場概要:各地區
  • 亞太地區的體外診斷市場概要:各產品類型
  • 亞太地區的體外診斷市場概要:各技術領域
  • 主要企業
  • 亞太地區的體外診斷市場:各國分析

第4章 南美

  • 南美的體外診斷市場概要:各地區
  • 南美的體外診斷市場概要:各產品類型
  • 南美的體外診斷市場概要:各技術領域
  • 主要企業
  • 南美的體外診斷市場:各國分析

第5章 其他地區

  • 各產品類型
  • 各技術領域

C部分:產業指南

  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

D部分:附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HC007

The In Vitro Diagnostics (IVD) industry is being positively impacted due to several factors that include rising global and regional trends of aging populations, growth in non-communicable diseases and greater affordability for treatment. Due to an increase in healthcare costs, greater weight is being given to evidence-based medicine with the aim of improving patient outcomes. The need for diagnostic devices in various conditions has been growing due to an aging population, growing epidemic of chronic diseases and (re)emergence of infectious diseases. A larger number of people are now gaining access to IVD due to growth in emerging countries and an impetus towards decentralized healthcare.

Nearly 68% of the global aged population resides in the developing economies and their population is increasing at a faster rate than that of developed regions. In fact, the population of aged individuals in developed economies has been exhibiting a declining trend, as can be seen from a fall of 38% in 2000 to 33% in 2015, which is likely to continue. This implies that the number of older people in the developing regions will grow over the coming decades.

The study analyzes the IVD product types including Reagents & Consumables and Instruments & Systems. This report exclusively analyzes the global IVD technology areas comprising Immunoassay, Blood Testing, Clinical Chemistry, Diabetes Testing, Molecular Diagnostics, Cellular Analysis, Pathology and Microbiology in terms of value in USD for 2014-2022 analysis period in the global markets comprising North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 16 independent countries across North America The United States, Canada and Mexico; Europe (Western Europe and Eastern Europe) Western Europe Germany, France, Italy, Spain, the United Kingdom, Belgium and Switzerland; and Eastern Europe Poland, Czech Republic and Romania; Asia-Pacific Japan, China and India; South America Argentina and Brazil.

Global IVD market grew from $55.8 billion in 2014 to US$62.6 billion in 2017 and the market is further expected to reach US$83.03 billion by 2022. Molecular Diagnostics is projected to record the fastest growing IVD technology segment with a CAGR of around 8% during 2017-2022 analysis period and to touch US$10.5 billion by 2022.

This 498 page global in-vitro diagnostics market report includes 270 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The report profiles 13 key global players and 44 major players across North America 26; Europe 14 and Asia-Pacific 4. The study also provides the listing of the companies engaged in IVD industry. The global list of companies covers the address, contact numbers and the website addresses of 335 companies.

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. In-Vitro Diagnostics Product Types
      • 1.1.1.1. Reagents
        • 1.1.1.1.1. General Purpose Reagents
        • 1.1.1.1.2. Analyte Specific Reagents
        • 1.1.1.1.3. Biochemical and Chemical Reagents
        • 1.1.1.1.4. Opting for the Optimal Biochemical and Chemical Reagents for IVD Tests
      • 1.1.1.2. Consumables
      • 1.1.1.3. Instruments & Systems
    • 1.1.2. In-Vitro Diagnostics Technologies Overview
      • 1.1.2.1. Clinical Chemistry
        • 1.1.2.1.1. Clinical Chemistry Analyzer/ Biochemistry Analyzer
      • 1.1.2.2. Immunoassays
        • 1.1.2.2.1. Objective of Immunoassays
        • 1.1.2.2.2. Immunoassay Methodologies
        • 1.1.2.2.3. Immunoassay Analyzer
          • 1.1.2.2.3.1. Principles of Immunoassay analyzer operation
      • 1.1.2.3. Diabetes Testing
        • 1.1.2.3.1. Primary Types of Diabetes
        • 1.1.2.3.2. Prediabetes
        • 1.1.2.3.3. Diagnosis of Diabetes and Pre-Diabetes
          • 1.1.2.3.3.1. Fasting Plasma Glucose (FPG) Test
          • 1.1.2.3.3.2. Oral Glucose Tolerance Test (OGTT)
          • 1.1.2.3.3.3. Random Plasma Glucose Test
          • 1.1.2.3.3.4. A1C test/ Glycated hemoglobin test
          • 1.1.2.3.3.5. Test Numbers representation to check whether a person have diabetes or not
        • 1.1.2.3.4. Blood Glucose Monitoring Devices
      • 1.1.2.4. Blood Testing
        • 1.1.2.4.1. Categories of Blood Tests
          • 1.1.2.4.1.1. Complete Blood Count (CBC)
          • 1.1.2.4.1.2. Red Blood Cells
          • 1.1.2.4.1.3. White Blood Cells
          • 1.1.2.4.1.4. Platelets
          • 1.1.2.4.1.5. Hemoglobin
          • 1.1.2.4.1.6. Hematocrit
          • 1.1.2.4.1.7. Mean Corpuscular Volume (MCV)
        • 1.1.2.4.2. Blood Chemistry Tests/Basic Metabolic Panel
        • 1.1.2.4.3. Blood Enzyme Tests
        • 1.1.2.4.4. Blood Tests to Assess Heart Disease Risk
        • 1.1.2.4.5. Reference Ranges for Blood Tests
        • 1.1.2.4.6. Analyzers
      • 1.1.2.5. Molecular Diagnostics
        • 1.1.2.5.1. Molecular Diagnostics Techniques
          • 1.1.2.5.1.1. Polymerase Chain Reaction (PCR) and Real-Time PCR
          • 1.1.2.5.1.2. Cytogenetic Analysis
          • 1.1.2.5.1.3. Fluorescent in situ Hybridization (FISH)
          • 1.1.2.5.1.4. Spectral Karyotype Imaging
          • 1.1.2.5.1.5. DNA Microarrays
          • 1.1.2.5.1.6. Personalized Medicine
        • 1.1.2.5.2. Molecular Diagnostics and Genome Research
        • 1.1.2.5.3. Sample Collection and Preparation
        • 1.1.2.5.4. Amplification and Detection Platforms and Assays
        • 1.1.2.5.5. Software Tools
        • 1.1.2.5.6. Complete Solutions
      • 1.1.2.6. Pathology
        • 1.1.2.6.1. Anatomical Pathology
        • 1.1.2.6.2. Chemical Pathology
        • 1.1.2.6.3. Clinical Pathology
        • 1.1.2.6.4. Forensic Pathology
        • 1.1.2.6.5. General Pathology
        • 1.1.2.6.6. Genetic Pathology
        • 1.1.2.6.7. Hematology Pathology
        • 1.1.2.6.8. Immunopathology
      • 1.1.2.7. Cellular Analysis
      • 1.1.2.8. Microbiology

2. IVD REGULATIONS & STANDARDS

  • 2.1. International Medical Device Regulators Forum and Global Harmonization Task Force (GHTF)
    • 2.1.1. General Classification System for IVD Medical Devices
  • 2.2. The United States
    • 2.2.1. IVD Classification
    • 2.2.2. Clinical Laboratory Improvement Amendments of 1988(CLIA '88)
    • 2.2.3. Premarket Notification 510(k)
    • 2.2.4. De Novo Classification for IVD Devices
    • 2.2.5. Premarket Approval (PMA)
    • 2.2.6. Requirements for IVD Labeling
    • 2.2.7. FDA Draft Guidances Designed to Consolidate Regulatory Oversight for Next-Generation Sequencing Tests
  • 2.3. Europe
    • 2.3.1. Directive 98/79/EC (IVDD)
    • 2.3.2. Essential Requirements for IVD Medical Devices
    • 2.3.3. Requirements that Apply to the Design and Manufacture of the Devices
    • 2.3.4. Product Groups
  • 2.4. China
    • 2.4.1. Provisions for In-vitro Diagnostic Reagent Registration
    • 2.4.2. Registration Procedure for Imported IVD Products
    • 2.4.3. IVD Type Testing Process for Imported IVDs
    • 2.4.4. Clinical Trials
  • 2.5. Japan
    • 2.5.1. Classification of IVDs
    • 2.5.2. Registration Requirements for IVDs
    • 2.5.3. Pre-market Approval (Shonin)
    • 2.5.4. Technical Specifications Required for Approval of Class III IVDs
    • 2.5.5. Pre-market Certification (Ninsho)
    • 2.5.6. Pre-market Submission (Todokede)
    • 2.5.7. Marketing Authorization Holder (Seihan)

3. KEY MARKET TRENDS

  • 3.1. Ageing Population and Burden of Disease Contribute to Growth in Demand for IVD
  • 3.2. Clinical Diagnostics Evolve to Prognostics and Predictive
  • 3.3. Next-Generation Sequencing Revolutionizes Clinical Applications
    • 3.3.1. Cancer Diagnostics and Treatment
    • 3.3.2. HLA/MHC Complex
    • 3.3.3. Neonatal and Prenatal Testing
    • 3.3.4. Pathogen Detection and Subtyping
  • 3.4. Pace of PCR Accelerated with Portable Diagnostic System
  • 3.5. Rapid DNA Test Offers Scope for Replacing PCR

4. KEY GLOBAL PLAYERS

  • Abbott Laboratories, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Biomerieux SA (France)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • ELITech Group (France)
  • ERBA Diagnostics Mannheim GmbH (Germany)
  • Hologic Inc. (United States)
  • Ortho Clinical Diagnostics (United States)
  • Roche Diagnostics Corporation (United States)
  • Siemens Healthineers, Inc. (United States)
  • Sysmex Corporation (Japan)
  • Wefen Group (Spain)

5. KEY BUSINESS & PRODUCT TRENDS

  • cobas MRSA/SA test Launched by Roche
  • ClearLLab Reagents Cleared by FDA for Specific Leukemia and Lymphoma Detection
  • FDA Approves Hologics Aptima HSV 1 & 2 Molecular Assay
  • CE Mark Allotted to Thermo Fishers Innovative Buprenorphine-Detecting Immunoassay
  • Oxford Gene Technology Taken Over by Sysmex Corp
  • Diagnostic Solutions for Combating Antimicrobial Resistance from BD
  • Abbott and Alere Agree at a Lower-Priced Deal
  • Roches CINtec Histology Test Granted FDA Approval
  • Beckman Coulters DxC 700 AU Chemistry Analyzer Cleared by FDA
  • Agilent Technologies Unveiled Postnatal Assay for Identifying Genetic Anomalies
  • Cepheids Xpert Xpress Flu and Xpert Xpress Flu/RSV Cleared by FDA
  • TruQuick Rapid Tests from Meridian Bioscience Introduced in Asia-Pacific
  • Accriva Diagnostics Acquired by WerfenLife
  • Abbott Acquires St. Jude Medical, Inc
  • PerkinElmer to Acquire Tulip Diagnostics Private Limited in India
  • Merck Launches New Calibration Kit for In-Vitro Diagnostic Use
  • Sekisui Diagnostics Unveils OSOM. BVBLUE. Rapid Test Service for Bacterial Vaginosis
  • bioMirieux and Banyan Biomarkers Collaborated to Develop Blood-Based Biomarkers for Traumatic Brain Injury
  • QIAGEN Unveils Novel CALR Mutation Assay for MPN Diagnosis
  • FDA CLIA Waiver for Sekisui Diagnostics OSOM. Ultra Flu A&B Test Solution
  • BD MAXVaginal Panel Obtains FDA Market Authorization to Identify Common Causes of Vaginal Infections
  • Celgene and Agios collaborated with Abbott
  • ARKRAY, Inc. Launched New Blood Glucose Test Meter
  • BD Vacutainer. BarricorTube Receives FDA 510(k) Approval for Innovative Blood Collection and Separation Technology
  • Becton, Dickinson Launches Next Generation Mobile Point-Of-Care Diagnostic Device
  • Bioline Unveils New SensiFASTLyo-Ready No-ROX Mix
  • Abbott Launches ALINITY, Novel Next Generation Diagnostic Systems
  • Thermo Fisher Scientific featured expanded Offerings for Clinical Applications at AACC 2016
  • Alere started Diagnostics manufacturing factory in India
  • Roche Unveils Innovative Accu-Chek Guide Blood Glucose Monitoring System
  • Siemens Healthcare Diagnostics Obtains FDAs Emergency Use Authorization for VERSANT. Zika RNA 1.0 Assay
  • WHO Prequalification for Alere HIV Combo Test
  • bioMirieux expanded its pathogen identification capability on VITEK. MS
  • ARKRAY, Inc. Unveiled Blood Glucose Meter for Dogs and cats
  • Hologic's Aptima. Zika Virus Assay obtained FDA Emergency Use Authorization
  • Ortho Clinical Diagnostics Obtained CE Mark Approval for VITROS. Immunodiagnostic HIV Combo Test
  • Beckman Coulter and Ortho Clinical Diagnostics Collaborated To Offer Infectious Disease Testing Menu to High-Volume Labs
  • Bio-Rad Launches Amplichek II Quality Control for the Molecular Diagnostics Testing Market
  • Quest Diagnostics Sold Focus Diagnostics Molecular and Immunoassay Business to DiaSorin S.p.A.
  • Siemens Healthcare and Thermo Fisher Formed Strategic Relationship in Molecular Testing
  • Ortho Clinical Diagnostics Announces Availability of ORTHOSera Extended Phenotype Testing on ORTHO VISION. Analyzer for BioVue. Cassettes
  • Thermo Fisher Scientific Inc Acquired Affymetrix, Inc.
  • Bio-Rad received CE IVD Marking for its QX200 Droplet Digital PCR System
  • Quest Diagnostics Enlarge Dako's PD-L1 IHC 28-8 Complementary Test Solution to Constitute Melanoma
  • ARKRAY, Inc expanded its operations by constructing integrated manufacturing system in Philippines
  • KHB Shanghai Kehua Bio-Engineering Acquires the Italian Technogenetics
  • Meridian Bioscience Invests in Oasis Diagnostics.
  • Biocartis Unveils Influenza-Respiratory Virus Panel on the Idyllaplatform
  • Focus Diagnostics SimplexaFlu A/B & RSV Direct Test Obtains FDA Approval to Include 53 New Virus Strains for the 2015-2016 Flu Season
  • Cepheid Obtains FDA Market Approval for Xpert TV, Test for Detecting Trichomonas Vaginalis Infection
  • QIAGENs RespiFast RG Improves Diagnosis of Respiratory Infections
  • Roche Acquires GeneWEAVE to bolster Offerings in Microbiology Diagnostics
  • Cepheid and FIND Launches World's Most Portable Molecular Diagnostics System, GeneXpert Omni
  • Roche Unveils point-of-care (POC) Troponin Test Solution to help Diagnose Heart Attack Patients at High Mortality Risk
  • Siemens HIV Combo Assay Obtained FDA Clearance
  • Ortho Clinical Diagnostics Obtains FDA 510(k) Approval for VITROS. Chemistry Products HbA1c Reagent Kit
  • QIAGEN and Biotype Diagnostics Enter into Joint Venture Agreement
  • QIAGEN and Hitachi High-Technologies Enters into Collaboration for Molecular Testing
  • Alere and FIND Collaborated to Develop New Rapid Diagnostic Tests for Simultaneous Detection of Malaria and Sleeping Sickness
  • Abbott's Unveiled Pioneering Blood Test solution to aid in detecting Early Pregnancy
  • Abbott Laboratories Inc and Sekisui Medical join forces
  • ARKRAY Launches Urine Analyzer thinka RT-4010 for Dogs and Cats
  • ARKRAY unveils new compact line-up of the existing reagent kit CinQ HbA1c
  • Cepheid Obtains FDAs Emergency Use Authorization for Xpert Ebola Diagnostic Test
  • Biocartis and Microbiome Collaborated to Develop Rapid and Sensitive Sepsis Test Solution
  • bioMirieux and Astute Medical associated to develop and market NephroCheck. Test for VIDAS., an assay to assess the risk of developing acute kidney injury

6. GLOBAL MARKET OVERVIEW

  • 6.1. Global In-Vitro Diagnostics Market Overview by Product Type
    • 6.1.1. Global In-Vitro Diagnostics Product Market Overview by Geographic Region
      • 6.1.1.1. Reagents & Consumables
      • 6.1.1.2. Instruments & Systems
  • 6.2. Global In-Vitro Diagnostics Market Overview by Technology Area
    • 6.2.1. Global In-Vitro Diagnostics Technology Market Overview by Geographic Region
      • 6.2.1.1. Clinical Chemistry
      • 6.2.1.2. Immunoassay
      • 6.2.1.3. Diabetes Testing
      • 6.2.1.4. Blood Testing
      • 6.2.1.5. Molecular Diagnostics
      • 6.2.1.6. Pathology
      • 6.2.1.7. Cellular Analysis
      • 6.2.1.8. Microbiology

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. NORTH AMERICA

  • 1.1. North American In-Vitro Diagnostics Market Overview by Geographic Region
  • 1.2. North American In-Vitro Diagnostics Market Overview by Product Type
    • 1.2.1. North American In-Vitro Diagnostics Product Type Market Overview by Geographic Region
      • 1.2.1.1. Reagents & Consumables
      • 1.2.1.2. Instruments & Systems
  • 1.3. North American In-Vitro Diagnostics Market Overview by Technology Area
    • 1.3.1. North American In-Vitro Diagnostics Technology Market Overview by Geographic Region
      • 1.3.1.1. Clinical Chemistry
      • 1.3.1.2. Immunoassay
      • 1.3.1.3. Diabetes Testing
      • 1.3.1.4. Blood Testing
      • 1.3.1.5. Molecular Diagnostics
      • 1.3.1.6. Pathology
      • 1.3.1.7. Cellular Analysis
      • 1.3.1.8. Microbiology
  • 1.4. Major Market Players
    • 3M Company (United States)
    • Abbott Laboratories, Inc. (United States)
    • Agilent Technologies, Inc. (United States)
    • Alere, Inc. (United States)
    • Beckman Coulter, Inc.
    • Becton, Dickinson And Company (United States)
    • BG Medicine, Inc. (United States)
    • Bio-Rad Laboratories, Inc. (United States)
    • Danaher Corporation (United States)
    • ERBA Diagnostics, Inc. (United States)
    • Hitachi Chemical Diagnostics (United States)
    • Hologic Inc. (United States)
    • Inova Diagnostics (United States)
    • Instrumentation Laboratory (United States)
    • Johnson & Johnson (United States)
    • Medtronic, Inc. (United States)
    • Merck Millipore (United States)
    • Meridian Bioscience, Inc. (United States)
    • MP Biomedicals LLC (United States)
    • Ortho Clinical Diagnostics (United States)
    • Perkinelmer, Inc. (United States)
    • Quest Diagnostics Inc (United States)
    • Roche Diagnostics Corporation (United States)
    • Sekisui Diagnostics LLC (United States)
    • Siemens Healthineers, Inc. (United States)
    • Thermo Fisher Scientific Inc. (United States)
  • 1.5. Country-wise Analysis of North American In-Vitro Diagnostics Market
    • 1.5.1. The United States
      • 1.5.1.1. United States In-Vitro Diagnostics Market Overview by Product Type
      • 1.5.1.2. United States In-Vitro Diagnostics Market Overview by Technology Area
      • 1.5.1.3. United States In vitro Diagnostics Market Overview by End-user
    • 1.5.2. Canada
      • 1.5.2.1. Canada In-Vitro Diagnostics Market Overview by Type
      • 1.5.2.2. Canada In-Vitro Diagnostics Market Overview by Technology Area
    • 1.5.3. Mexico
      • 1.5.3.1. Mexico In-Vitro Diagnostics Market Overview by Product Type
      • 1.5.3.2. Mexico In-Vitro Diagnostics Market Overview by Technology Area

2. EUROPE

  • 2.1. European In-Vitro Diagnostics Market Overview by Geographic Region
  • 2.2. European In-Vitro Diagnostics Market Overview by Product Type
  • 2.3. European In-Vitro Diagnostics Market Overview by Technology Area
  • 2.4. Major Market Players
    • Ascensia Diabetes Care Holdings AG (Switzerland)
    • Biocartis NV (Belgium)
    • Biomerieux SA (France)
    • Elitech Group (France)
    • ERBA Diagnostics Mannheim GmbH (Germany)
    • Eurogentec S.A (Belgium)
    • GE Healthcare Limited (United Kingdom)
    • Hemocue AB (Sweden)
    • KEM-EN-TEC Diagnostics A/S (Denmark)
    • LEICA Biosystems (Germany)
    • Novo Nordisk A/S (Denmark)
    • Qiagen N.V. (Netherlands)
    • Radiometer Medical Aps (Denmark)
    • Wefen Group (Spain)
  • 2.5. European In-Vitro Diagnostics Market Overview by European Sub-Region
    • 2.5.1. Western Europe
      • 2.5.1.1. Western European In-Vitro Diagnostics Market Overview by Geographic Region
      • 2.5.1.2. Western European In-Vitro Diagnostics Market Overview by Product Type
        • 2.5.1.2.1. Western European In-Vitro Diagnostics Product Market Overview by Geographic Region
          • 2.5.1.2.1.1. Reagents & Consumables
          • 2.5.1.2.1.2. Instruments & Systems
      • 2.5.1.3. Western European In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.3.1. Western European In-Vitro Diagnostics Technology Market Overview by Geographic Region
          • 2.5.1.3.1.1. Clinical Chemistry
          • 2.5.1.3.1.2. Immunoassay
          • 2.5.1.3.1.3. Diabetes Testing
          • 2.5.1.3.1.4. Blood Testing
          • 2.5.1.3.1.5. Molecular Diagnostics
          • 2.5.1.3.1.6. Pathology
          • 2.5.1.3.1.7. Cellular Analysis
          • 2.5.1.3.1.8. Microbiology
      • 2.5.1.4. Country-wise Analysis of Western European In-Vitro Diagnostics Market
        • 2.5.1.4.1. Germany
          • 2.5.1.4.1.1. German In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.1.2. German In-Vitro Diagnostics Market Overview by Technology Area
          • 2.5.1.4.1.3. German In-Vitro Diagnostics Market Overview by End-user
        • 2.5.1.4.2. France
          • 2.5.1.4.2.1. French In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.2.2. French In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.3. Italy
          • 2.5.1.4.3.1. Italian In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.3.2. Italian In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.4. Spain
          • 2.5.1.4.4.1. Spanish In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.4.2. Spanish In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.5. The United Kingdom
          • 2.5.1.4.5.1. United Kingdom In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.5.2. United Kingdom In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.6. Belgium
          • 2.5.1.4.6.1. Belgium In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.6.2. Belgium In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.7. Switzerland
          • 2.5.1.4.7.1. Swiss In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.7.2. Swiss In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.1.4.8. Rest of Western Europe
          • 2.5.1.4.8.1. Rest of Western Europe In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.1.4.8.2. Rest of Western Europe In-Vitro Diagnostics Market Overview by Technology Area
    • 2.5.2. Eastern Europe
      • 2.5.2.1. Eastern European In-Vitro Diagnostics Market Overview by Geographic Region
      • 2.5.2.2. Eastern European In-Vitro Diagnostics Market Overview by Product Type
        • 2.5.2.2.1. Eastern European In-Vitro Diagnostics Product Market Overview by Geographic Region
          • 2.5.2.2.1.1. Reagents & Consumables
          • 2.5.2.2.1.2. Instruments & Systems
      • 2.5.2.3. Eastern European In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.2.3.1. Eastern European In-Vitro Diagnostics Technology Market Overview by Geographic Region
          • 2.5.2.3.1.1. Clinical Chemistry
          • 2.5.2.3.1.2. Immunoassay
          • 2.5.2.3.1.3. Diabetes Testing
          • 2.5.2.3.1.4. Blood Testing
          • 2.5.2.3.1.5. Molecular Diagnostics
          • 2.5.2.3.1.6. Pathology
          • 2.5.2.3.1.7. Cellular Analysis
          • 2.5.2.3.1.8. Microbiology
      • 2.5.2.4. Country-wise Analysis of Eastern European In-Vitro Diagnostics Market
        • 2.5.2.4.1. Poland
          • 2.5.2.4.1.1. Polish In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.2.4.1.2. Polish In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.2.4.2. Czech Republic
          • 2.5.2.4.2.1. Czech Republic In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.2.4.2.2. Czech Republic In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.2.4.3. Romania
          • 2.5.2.4.3.1. Romania In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.2.4.3.2. Romania In-Vitro Diagnostics Market Overview by Technology Area
        • 2.5.2.4.4. Rest of Eastern Europe
          • 2.5.2.4.4.1. Rest of Eastern Europe In-Vitro Diagnostics Market Overview by Product Type
          • 2.5.2.4.4.2. Rest of Eastern Europe In-Vitro Diagnostics Market Overview by Technology Area

3. ASIA-PACIFIC

  • 3.1. Asia-Pacific In-Vitro Diagnostics Market Overview by Geographic Region
  • 3.2. Asia-Pacific In-Vitro Diagnostics Market Overview by Product Type
    • 3.2.1. Asia-Pacific In-Vitro Diagnostics Product Market Overview by Geographic Region
      • 3.2.1.1. Reagents & Consumables
      • 3.2.1.2. Instruments & Systems
  • 3.3. Asia-Pacific In-Vitro Diagnostics Market Overview by Technology Area
    • 3.3.1. Asia-Pacific In-Vitro Diagnostics Technology Market Overview by Geographic Region
      • 3.3.1.1. Clinical Chemistry
      • 3.3.1.2. Immunoassay
      • 3.3.1.3. Diabetes Testing
      • 3.3.1.4. Blood Testing
      • 3.3.1.5. Molecular Diagnostics
      • 3.3.1.6. Pathology
      • 3.3.1.7. Cellular Analysis
      • 3.3.1.8. Microbiology
  • 3.4. Major Market Players
    • Arkray, Inc. (Japan)
    • Shanghai Kehua Bio-Engineering (China)
    • Sysmex Corporation (Japan)
    • Transasia Bio-Medicals Ltd (India)
  • 3.5. Country-wise Analysis of Asia-Pacific In-Vitro Diagnostics Market
    • 3.5.1. Japan
      • 3.5.1.1. Japanese In-Vitro Diagnostics Market Overview by Product Type
      • 3.5.1.2. Japanese In-Vitro Diagnostics Market Overview by Technology Area
    • 3.5.2. China
      • 3.5.2.1. Chinese In-Vitro Diagnostics Market Overview by Product Type
      • 3.5.2.2. Chinese In-Vitro Diagnostics Market Overview by Technology Area
    • 3.5.3. India
      • 3.5.3.1. Indian In-Vitro Diagnostics Market Overview by Product Type
      • 3.5.3.2. Indian In-Vitro Diagnostics Market Overview by Technology Area
    • 3.5.4. Rest of Asia-Pacific
      • 3.5.4.1. Rest of Asia-Pacific In-Vitro Diagnostics Market Overview by Product Type
      • 3.5.4.2. Rest of Asia-Pacific In-Vitro Diagnostics Market Overview by Technology Area

4. SOUTH AMERICA

  • 4.1. South American In-Vitro Diagnostics Market Overview by Geographic Region
  • 4.2. South American In-Vitro Diagnostics Market Overview by Product Type
    • 4.2.1. South American In-Vitro Diagnostics Product Market Overview by Geographic Region
      • 4.2.1.1. Reagents & Consumables
      • 4.2.1.2. Instruments & Systems
  • 4.3. South American In-Vitro Diagnostics Market Overview by Technology Area
    • 4.3.1. South American In-Vitro Diagnostics Technology Market Overview by Geographic Region
      • 4.3.1.1. Clinical Chemistry
      • 4.3.1.2. Immunoassay
      • 4.3.1.3. Diabetes Testing
      • 4.3.1.4. Blood Testing
      • 4.3.1.5. Molecular Diagnostics
      • 4.3.1.6. Pathology
      • 4.3.1.7. Cellular Analysis
      • 4.3.1.8. Microbiology
  • 4.4. Country-wise Analysis of South American In-Vitro Diagnostics Market
    • 4.4.1. Argentina
      • 4.4.1.1. Argentinean In-Vitro Diagnostics Market Overview by Product Type
      • 4.4.1.2. Argentinean In-Vitro Diagnostics Market Overview by Technology Area
    • 4.4.2. Brazil
      • 4.4.2.1. Brazilian In-Vitro Diagnostics Market Overview by Product Type
      • 4.4.2.2. Brazilian In-Vitro Diagnostics Market Overview by Technology Area
    • 4.4.3. Rest of South America
      • 4.4.3.1. Rest of South American In-Vitro Diagnostics Market Overview by Product Type
      • 4.4.3.2. Rest of South American In-Vitro Diagnostics Market Overview by Technology Area

5. REST OF WORLD

  • 5.1. Rest of World In-Vitro Diagnostics Market Overview by Product Type
  • 5.2. Rest of World In-Vitro Diagnostics Market Overview by Technology Area

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global In-Vitro Diagnostics Market (2014, 2017 and 2022)
  • Chart 2: Global In-Vitro Diagnostics Market (2017 and 2022) by Geographic Region
  • Chart 3: Global In-Vitro Diagnostics Market (2017 and 2022) by Technology Area
  • Chart 4: Global IVD Market (2017 & 2022) in Clinical Chemistry by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 5: Global IVD Market (2017 & 2022) in Immunoassay by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 6: Global IVD Market (2017 & 2022) in Diabetes Testing by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 7: Global IVD Market (2017 & 2022) in Blood Testing by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 8: Global IVD Market (2017 & 2022) in Molecular Diagnostics by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 9: Global IVD Market (2017 & 2022) in Pathology by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 10: Global IVD Market (2017 & 2022) in Cellular Analysis by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 11: Global IVD Market (2017 & 2022) in Microbiology by Geographic Region North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 12: Global In-Vitro Diagnostics Market Analysis (2014-2022) in USD Million
  • Chart 13: Global In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 14: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 15: Global In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 16: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 17: Global In-Vitro Diagnostics Instruments & Systems Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 18: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Instruments & Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 19: Global In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 20: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 21: Global In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 22: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 23: Global In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 24: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Immunoassay Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 25: Global In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 26: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 27: Global In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 28: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 29: Global In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 30: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 31: Global In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 32: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 33: Global In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 34: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 35: Global In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 36: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 37: Global In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 38: Glance at 2014, 2017 and 2022 Global In-Vitro Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 39: North American In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 40: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 41: North American In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 42: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 43: North American In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 44: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 45: North American In-Vitro Diagnostics Instruments & Systems Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 46: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Instruments & Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 47: North American In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 48: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 49: North American In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 50: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 51: North American In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 52: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Immunoassay Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 53: North American In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 54: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 55: North American In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 56: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 57: North American In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 58: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 59: North American In-Vitro Diagnostics Pathology Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 60: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 61: North American In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 62: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 63: North American In-Vitro Diagnostics Microbiology Market Analysis (2014-2022) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 64: Glance at 2014, 2017 and 2022 North American In-Vitro Diagnostics Microbiology Market Share (%) by Geographic Region - United States, Canada and Mexico

The United States

  • Chart 65: United States In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 66: Glance at 2014, 2017 and 2022 United States In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 67: United States In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 68: Glance at 2014, 2017 and 2022 United States In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 69: United States In-Vitro Diagnostics Market Analysis (2014-2022) by End-user - Hospitals, Laboratories, Outpatient, Homecare and Others in USD Million
  • Chart 70: Glance at 2014, 2017 and 2022 United States In-Vitro Diagnostics Market Share (%) by End User - Hospitals, Laboratories, Outpatient, Homecare and Others

Canada

  • Chart 71: Canadian In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 72: Glance at 2014, 2017 and 2022 Canadian In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 73: Canadian In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 74: Glance at 2014, 2017 and 2022 Canadian In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Mexico

  • Chart 75: Canadian In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 76: Glance at 2014, 2017 and 2022 Mexican In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 77: Mexican In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 78: Glance at 2014, 2017 and 2022 Mexican In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

EUROPE

  • Chart 79: European In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - Western Europe and Eastern Europe in USD Million
  • Chart 80: Glance at 2014, 2017 and 2022 European In-Vitro Diagnostics Market Share (%) by Geographic Region - Western Europe and Eastern Europe
  • Chart 81: European In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 82: Glance at 2014, 2017 and 2022 European In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 83: European In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 84: Glance at 2014, 2017 and 2022 European In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Western Europe

  • Chart 85: Western European In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 86: Glance at 2014, 2017 and 2022 Western Europe In-Vitro Diagnostics Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 87: Western European In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 88: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 89: Western European In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 90: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 91: Western European In-Vitro Diagnostics Instruments & Systems Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 92: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Instruments & Systems Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 93: Western European In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 94: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 95: Western European In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 96: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 97: Western European In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 98: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Immunoassay Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 99: Western European In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 100: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 101: Western European In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 102: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 103: Western European In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 104: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 105: Western European In-Vitro Diagnostics Pathology Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 106: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 107: Western European In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 108: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe
  • Chart 109: Western European In-Vitro Diagnostics Microbiology Market Analysis (2014-2022) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe in USD Million
  • Chart 110: Glance at 2014, 2017 and 2022 Western European In-Vitro Diagnostics Microbiology Market Share (%) by Geographic Region - Germany, France, Italy, Spain, United Kingdom, Belgium, Switzerland and Rest of Western Europe

Germany

  • Chart 111: German In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 112: Glance at 2014, 2017 and 2022 German In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 113: German In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 114: Glance at 2014, 2017 and 2022 German In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 115: German In-Vitro Diagnostics Market Analysis (2014-2022) by End-user - Hospitals, Laboratories, Home Care and Others in USD Million
  • Chart 116: Glance at 2014, 2017 and 2022 German In-Vitro Diagnostics Market Share (%) by End Users - Hospitals, Laboratories, Home Care and Others

France

  • Chart 117: French In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 118: Glance at 2014, 2017 and 2022 French In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 119: French In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 120: Glance at 2014, 2017 and 2022 French In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Italy

  • Chart 121: Italian In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 122: Glance at 2014, 2017 and 2022 Italian In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 123: Italian In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 124: Glance at 2014, 2017 and 2022 Italian In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Spain

  • Chart 125: Spanish In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 126: Glance at 2014, 2017 and 2022 Spanish In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 127: Spanish In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 128: Glance at 2014, 2017 and 2022 Spanish In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

The United Kingdom

  • Chart 129: United Kingdom In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 130: Glance at 2014, 2017 and 2022 United Kingdom In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 131: United Kingdom In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 132: Glance at 2014, 2017 and 2022 United Kingdom In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Belgium

  • Chart 133: Belgium In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 134: Glance at 2014, 2017 and 2022 Belgium In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 135: Belgium In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 136: Glance at 2014, 2017 and 2022 Belgium In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Switzerland

  • Chart 137: Swiss In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 138: Glance at 2014, 2017 and 2022 Swiss In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 139: Swiss In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 140: Glance at 2014, 2017 and 2022 Swiss In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Rest of Western Europe

  • Chart 141: Rest of Western Europe In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 142: Glance at 2014, 2017 and 2022 Rest of Western Europe In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 143: Rest of Western Europe In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 144: Glance at 2014, 2017 and 2022 Rest of Western Europe In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Eastern Europe

  • Chart 145: Eastern European In-Vitro-Diagnostics Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 146: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 147: Eastern European In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 148: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 149: Eastern European In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 150: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 151: Eastern European In-Vitro Diagnostics Instrument & Systems Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 152: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 153: Eastern European In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 154: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 155: Eastern European In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 156: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 157: Eastern European In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 158: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 159: Eastern European In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 160: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 161: Eastern European In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 162: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 163: Eastern European In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 164: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 165: Eastern European In-Vitro Diagnostics Pathology Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 166: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 167: Eastern European In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 168: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe
  • Chart 169: Eastern European In-Vitro Diagnostics Microbiology Market Analysis (2014-2022) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe in USD Million
  • Chart 170: Glance at 2014, 2017 and 2022 Eastern European In-Vitro Diagnostics Microbiology Market Share (%) by Geographic Region - Poland, Czech Republic, Romania and Rest of East Europe

Poland

  • Chart 171: Polish In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 172: Glance at 2014, 2017 and 2022 Polish In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 173: Polish In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 174: Glance at 2014, 2017 and 2022 Polish In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Czech Republic

  • Chart 175: Czech Republic In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 176: Glance at 2014, 2017 and 2022 Czech Republic In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 177: Czech Republic In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 178: Glance at 2014, 2017 and 2022 Czech Republic In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Romania

  • Chart 179: Romania In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 180: Glance at 2014, 2017 and 2022 Romania In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 181: Romania In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 182: Glance at 2014, 2017 and 2022 Romania In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Rest of Eastern Europe
  • Chart 183: Rest of Eastern Europe In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 184: Glance at 2014, 2017 and 2022 Rest of Eastern Europe In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 185: Rest of Eastern Europe In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 186: Glance at 2014, 2017 and 2022 Rest of Eastern Europe In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

ASIA-PACIFIC

  • Chart 187: Asia-Pacific In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 188: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 189: Asia-Pacific In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 190: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 191: Asia-Pacific In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 192: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 193: Asia-Pacific In-Vitro Diagnostics Instruments & Systems Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 194: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Instruments & Systems Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 195: Asia-Pacific In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 196: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 197: Asia-Pacific In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 198: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 199: Asia-Pacific In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 200: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Immunoassay Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 201: Asia-Pacific In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 202: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 203: Asia-Pacific In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 204: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 205: Asia-Pacific In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 206: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 207: Asia-Pacific In-Vitro Diagnostics Pathology Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 208: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 209: Asia-Pacific In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 210: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
  • Chart 211: Asia-Pacific In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
  • Chart 212: Glance at 2014, 2017 and 2022 Asia-Pacific In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific

Japan

  • Chart 213: Japanese In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 214: Glance at 2014, 2017 and 2022 Japanese In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 215: Japanese In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 216: Glance at 2014, 2017 and 2022 Japanese In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

China

  • Chart 217: Chinese In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 218: Glance at 2014, 2017 and 2022 Chinese In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 219: Chinese In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 220: Glance at 2014, 2017 and 2022 Chinese In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

India

  • Chart 221: Indian In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 222: Glance at 2014, 2017 and 2022 Indian In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 223: Indian In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 224: Glance at 2014, 2017 and 2022 Indian In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Rest of Asia-Pacific
  • Chart 225: Rest of Asia-Pacific In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 226: Glance at 2014, 2017 and 2022 Rest of Asia-Pacific In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 227: Rest of Asia-Pacific In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 228: Glance at 2014, 2017 and 2022 Rest of Asia-Pacific In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

SOUTH AMERICA

  • Chart 229: South American In-Vitro Diagnostics Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 230: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 231: South American In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 232: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 233: South American In-Vitro Diagnostics Reagents & Consumables Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 234: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 235: South American In-Vitro Diagnostics Instruments & Systems Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 236: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Instruments & Systems Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 237: South American In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 238: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Chart 239: South American In-Vitro Diagnostics Clinical Chemistry Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 240: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Clinical Chemistry Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 241: South American In-Vitro Diagnostics Immunoassay Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 242: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Immunoassay Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 243: South American In-Vitro Diagnostics Diabetes Testing Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 244: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Diabetes Testing Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 245: South American In-Vitro Diagnostics Blood Testing Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 246: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Blood Testing Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 247: South American In-Vitro Diagnostics Molecular Diagnostics Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 248: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Molecular Diagnostics Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 249: South American In-Vitro Diagnostics Pathology Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 250: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Pathology Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 251: South American In-Vitro Diagnostics Cellular Analysis Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 252: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Cellular Analysis Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 253: South American In-Vitro Diagnostics Microbiology Market Analysis (2014-2022) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 254: Glance at 2014, 2017 and 2022 South American In-Vitro Diagnostics Microbiology Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America

Argentina

  • Chart 255: Argentinean In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 256: Glance at 2014, 2017 and 2022 Argentinean In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 257: Argentinean In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 258: Glance at 2014, 2017 and 2022 Argentinean In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Brazil

  • Chart 259: Brazilian In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 260: Glance at 2014, 2017 and 2022 Brazilian In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 261: Brazilian In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 262: Glance at 2014, 2017 and 2022 Brazilian In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology
  • Rest of South America
  • Chart 263: Rest of South America In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 264: Glance at 2014, 2017 and 2022 Rest of South America In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 265: Rest of South America In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 266: Glance at 2014, 2017 and 2022 Rest of South America In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

REST OF WORLD

  • Chart 267: Rest of World In-Vitro Diagnostics Market Analysis (2014-2022) by Product Type - Reagents & Consumables and Instruments & Systems in USD Million
  • Chart 268: Glance at 2014, 2017 and 2022 Rest of World In-Vitro Diagnostics Market Share (%) by Product Type - Reagents & Consumables and Instruments & Systems
  • Chart 269: Rest of World In-Vitro Diagnostics Market Analysis (2014-2022) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology in USD Million
  • Chart 270: Glance at 2014, 2017 and 2022 Rest of World In-Vitro Diagnostics Market Share (%) by Technology Area - Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology

Tables:

  • Table 1: Types of Consumables Used in In-Vitro Diagnostics (IVD)
  • Table 2: In-Vitro Diagnostics (IVD) Instruments and Systems or Equipment
  • Table 3: Classification of IVD Reagents and Instruments by Technology Area
  • Table 4: Classification of Clinical Chemistry Tests
  • Table 5: Methodologies Used for Immunoassay Tests
  • Table 6: Classification and Formats of Immunoassays
  • Table 7: Types of Blood Glucose Monitoring Devices
  • Table 8: Types of Basic Metabolic Panel (BMP) Tests
  • Table 9: Sub-Disciplines of Microbiology
  • Table 10: CFDA Classification of IVD Products
  • Table 11: Population Aged 60 Years or Over and Aged 80 Years or Over for The World, Development Groups, Regions and Income Groups (2000, 2015, 2030 and 2050)
Back to Top